$256.00
The 20mg value format of OVA’s triple-agonist peptide — designed for women on established retatrutide protocols managing long-term body composition and metabolic health.
3-5 business days
SSL encrypted
Retatrutide’s triple agonism — GLP-1, GIP, and glucagon — means it addresses fat loss from appetite, adipose metabolism, and energy expenditure simultaneously. The 20mg vial is designed for women who have completed titration and are established at a weekly maintenance dose, offering cost efficiency over multiple weeks of protocol.
Beyond body composition, retatrutide’s glucagon component shows promise for improving liver health (reducing hepatic steatosis), and its combined metabolic effects may have cardiovascular benefits beyond weight loss alone. For women who have experienced the ceiling effects of GLP-1 monotherapy, the addition of glucagon receptor activation often produces continued progress where other peptides plateau.
Female-calibrated dosing: This format supports multiple weeks at standard doses (6–12mg weekly). Reconstitute with bacteriostatic water at a concentration appropriate for your maintenance dose. Work with your practitioner to determine exact volume and frequency. Most women find sustained results at 8mg weekly with the 20mg vial covering approximately 2.5 weeks of protocol.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 28 days.
| Dosage | 20mg |
|---|---|
| Format | Injectable Vial |
| Cycle Length | Ongoing |
| Storage | Freeze until use. Refrigerate after reconstitution. Use within 28 days. |
Reviews
There are no reviews yet.